Literature DB >> 9529348

Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI.

B Burwinkel1, H D Bakker, E Herschkovitz, S W Moses, Y S Shin, M W Kilimann.   

Abstract

Deficiency of glycogen phosphorylase in the liver gives rise to glycogen-storage disease type VI (Hers disease; MIM 232700). We report the identification of the first mutations in PYGL, the gene encoding the liver isoform of glycogen phosphorylase, in three patients with Hers disease. These are two splice-site mutations and two missense mutations. A mutation of the 5' splice-site consensus of intron 14 causes the retention of intron 14 and the utilization of two illegitimate 5' splice sites, whereas a mutation of the 3' splice-site consensus of intron 4 causes the skipping of exon 5. Two missense mutations, N338S and N376K, both cause nonconservative replacements of amino acids that are absolutely conserved even in yeast and bacterial phosphorylases. We also report corrections of the PYGL coding sequence, sequence polymorphisms, and a partial PYGL gene structure with introns in the same positions as in PYGM, the gene of the muscle isoform of phosphorylase. Our findings demonstrate that PYGL mutations cause Hers disease, and they may improve laboratory diagnosis of deficiencies of the liver phosphorylase system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9529348      PMCID: PMC1377030          DOI: 10.1086/301790

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  21 in total

1.  [Enzymatic studies of hepatic fragments; application to the classification of glycogenoses].

Authors:  H G HERS
Journal:  Rev Int Hepatol       Date:  1959

2.  Biochemical diagnosis of hepatic glycogen storage diseases: 20 years French experience.

Authors:  I Maire; C Baussan; N Moatti; M Mathieu; A Lemonnier
Journal:  Clin Biochem       Date:  1991-04       Impact factor: 3.281

3.  Glycogen phosphorylase and its converter enzymes in haemolysates of normal human subjects and of patients with type VI glycogen-storage disease. A study of phosphorylase kinase deficiency.

Authors:  B Lederer; F Van Hoof; G Van den Berghe; H Hers
Journal:  Biochem J       Date:  1975-04       Impact factor: 3.857

4.  Intron/exon structure of the human gene for the muscle isozyme of glycogen phosphorylase.

Authors:  J Burke; P Hwang; L Anderson; R Lebo; F Gorin; R Fletterick
Journal:  Proteins       Date:  1987

5.  Quantitation of muscle glycogen phosphorylase mRNA and enzyme amounts in adult rat tissues.

Authors:  E S David; M M Crerar
Journal:  Biochim Biophys Acta       Date:  1986-01-15

6.  Human brain glycogen phosphorylase. Cloning, sequence analysis, chromosomal mapping, tissue expression, and comparison with the human liver and muscle isozymes.

Authors:  C B Newgard; D R Littman; C van Genderen; M Smith; R J Fletterick
Journal:  J Biol Chem       Date:  1988-03-15       Impact factor: 5.157

7.  Human liver glycogen phosphorylase. Kinetic properties and assay in biopsy specimens.

Authors:  B Lederer; W Stalmans
Journal:  Biochem J       Date:  1976-12-01       Impact factor: 3.857

8.  Evolution of allosteric control in glycogen phosphorylase.

Authors:  J W Hudson; G B Golding; M M Crerar
Journal:  J Mol Biol       Date:  1993-12-05       Impact factor: 5.469

9.  Use of platelets, mononuclear and polymorphonuclear cells in the diagnosis of glycogen storage disease type VI.

Authors:  N Dahan; C Baussan; N Moatti; A Lemonnier
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

10.  Sequence analysis of the cDNA encoding human liver glycogen phosphorylase reveals tissue-specific codon usage.

Authors:  C B Newgard; K Nakano; P K Hwang; R J Fletterick
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

View more
  19 in total

1.  Glycogen phosphorylase, the product of the glgP Gene, catalyzes glycogen breakdown by removing glucose units from the nonreducing ends in Escherichia coli.

Authors:  Nora Alonso-Casajús; David Dauvillée; Alejandro Miguel Viale; Francisco José Muñoz; Edurne Baroja-Fernández; María Teresa Morán-Zorzano; Gustavo Eydallin; Steven Ball; Javier Pozueta-Romero
Journal:  J Bacteriol       Date:  2006-07       Impact factor: 3.490

Review 2.  Glycogen metabolism and glycogen storage disorders.

Authors:  Shibani Kanungo; Kimberly Wells; Taylor Tribett; Areeg El-Gharbawy
Journal:  Ann Transl Med       Date:  2018-12

Review 3.  Growth in patients with type 1 diabetes.

Authors:  Deborah M Mitchell
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-02       Impact factor: 3.243

4.  No Dataset Left Behind: Mechanistic Insights into Thyroid Receptor Signaling Through Transcriptomic Consensome Meta-Analysis.

Authors:  Scott A Ochsner; Neil J McKenna
Journal:  Thyroid       Date:  2020-01-29       Impact factor: 6.568

Review 5.  The Phenotypic and Genetic Spectrum of Glycogen Storage Disease Type VI.

Authors:  Sarah Catharina Grünert; Luciana Hannibal; Ute Spiekerkoetter
Journal:  Genes (Basel)       Date:  2021-08-03       Impact factor: 4.096

6.  Computational Study of Asian Propolis Compounds as Potential Anti-Type 2 Diabetes Mellitus Agents by Using Inverse Virtual Screening with the DIA-DB Web Server, Tanimoto Similarity Analysis, and Molecular Dynamic Simulation.

Authors:  Putri Hawa Syaifie; Azza Hanif Harisna; Mochammad Arfin Fardiansyah Nasution; Adzani Gaisani Arda; Dwi Wahyu Nugroho; Muhammad Miftah Jauhar; Etik Mardliyati; Nurwenda Novan Maulana; Nurul Taufiqu Rochman; Alfian Noviyanto; Antonio J Banegas-Luna; Horacio Pérez-Sánchez
Journal:  Molecules       Date:  2022-06-21       Impact factor: 4.927

7.  High frequency of missense mutations in glycogen storage disease type VI.

Authors:  N J Beauchamp; J Taybert; M P Champion; V Layet; P Heinz-Erian; A Dalton; M S Tanner; E Pronicka; M J Sharrard
Journal:  J Inherit Metab Dis       Date:  2007-08-21       Impact factor: 4.982

Review 8.  Glycogen storage diseases: new perspectives.

Authors:  Hasan Ozen
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

9.  An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia.

Authors:  S M Poucher; S Freeman; S J G Loxham; G Convey; J B Bartlett; J De Schoolmeester; J Teague; M Walker; A V Turnbull; A D Charles; F Carey; S Berg
Journal:  Br J Pharmacol       Date:  2007-10-15       Impact factor: 8.739

10.  The human cardiac and skeletal muscle proteomes defined by transcriptomics and antibody-based profiling.

Authors:  Cecilia Lindskog; Jerker Linné; Linn Fagerberg; Björn M Hallström; Carl Johan Sundberg; Malene Lindholm; Mikael Huss; Caroline Kampf; Howard Choi; David A Liem; Peipei Ping; Leif Väremo; Adil Mardinoglu; Jens Nielsen; Erik Larsson; Fredrik Pontén; Mathias Uhlén
Journal:  BMC Genomics       Date:  2015-06-25       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.